Monika Rudzińska

Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER)

Claudia Trenkwalder, Bryan Kies, Monika Rudzińska et al. · Movement Disorders · 2010 · 439 citations · Full text

An exploratory double‐blind, randomized clinical trial with selisistat, a <scp>SirT1</scp> inhibitor, in patients with <scp>H</scp>untington's disease

Sigurd D. Süßmuth, Salman Haider, G. Bernhard Landwehrmeyer et al. · British Journal of Clinical Pharmacology · 2014 · 161 citations · Full text

Cognitive impairment and BDNF serum levels

Joanna Siuda, Maja Patalong‐Ogiewa, Weronika Żmuda et al. · Neurologia i Neurochirurgia Polska · 2016 · 131 citations

Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial

Peter A. LeWitt, Robert A. Hauser, Rajesh Pahwa et al. · The Lancet Neurology · 2019 · 114 citations

Placebo-controlled Phase 3, Parkinson Disease, Motor Disorder +5

Role of Gα(olf) in familial and sporadic adult-onset primary dystonia

Satya R. Vemula, Andreas Puschmann, Jianfeng Xiao et al. · Human Molecular Genetics · 2013 · 108 citations · Full text